Sign in
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells)
Journal article   Open access

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells)

Emerson C Perin, Michael P Murphy, Keith L March, Roberto Bolli, John Loughran, Phillip C Yang, Nicholas J Leeper, Ronald L Dalman, Jason Alexander, Timothy D Henry, …
Circulation (New York, N.Y.), Vol.135(15), pp.1417-1428
2017-04-11
PMID: 28209728

Abstract

Peripheral Arterial Disease - metabolism Cell- and Tissue-Based Therapy - methods Follow-Up Studies Comorbidity Humans Middle Aged Risk Factors Male Treatment Outcome Peripheral Arterial Disease - therapy Exercise Extremities - blood supply Peripheral Arterial Disease - diagnosis Perfusion Bone Marrow Transplantation Quality of Life Female Aged Intermittent Claudication - therapy Aldehyde Dehydrogenase - metabolism Bone Marrow Cells - metabolism Cell- and Tissue-Based Therapy - adverse effects
url
https://doi.org/10.1161/CIRCULATIONAHA.116.025707View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.168 Vascular, Cardiac & Thoracic Surgery
1.168.699 Peripheral Arterial Disease
Web Of Science research areas
Cardiac & Cardiovascular Systems
Peripheral Vascular Disease
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details